Crossmark

Hyaluronic acid grafted nanoparticles of a platinum(<scp>ii</scp>)–silicon(<scp>iv</scp>) phthalocyanine conjugate for tumor and mitochondria-targeted photodynamic therapy in red light

Crossref DOI link: https://doi.org/10.1039/C8TB02533A

Published Online: 2018

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Mitra, Koushambi https://orcid.org/0000-0003-4325-453X
Samsó, Montserrat

Lyons, Charles E.

Hartman, Matthew C. T. https://orcid.org/0000-0003-0210-1422
Funding

Funding for this research was provided by:

National Cancer Institute (5P30CA16059)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR068431)
License Information

Accepted Manuscript valid from 2019-10-24
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Koushambi Mitra (ORCID)

: Matthew C. T. Hartman (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 26 September 2018; Accepted 15 October 2018; Advance Article published 24 October 2018; Version of Record published 21 November 2018

Document is current

Any future updates will be listed below